27th Feb 2024 A plain language summary: BI 1015550 for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
27th Feb 2024 A plain language summary looking at spesolimab treatment for the prevention of flares in people with generalized pustular psoriasis (GPP)
14th Nov 2023 Plain Language Summary of Publication article: the GENEr8-1 study of valoctocogene roxaparvovec gene therapy for hemophilia A
22nd Sep 2023 A plain language summary of the HIMALAYA study which looked at tremelimumab and durvalumab for unresectable hepatocellular carcinoma
9th Aug 2023 The MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma- a plain language summary
11th Jul 2023 Plain Language Summary: the CARTITUDE-1 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
27th Jun 2023 Plain Language Summary: what can clinical studies tell us about evobrutinib, a potential treatment for multiple sclerosis
7th Jun 2023 Plain Language Summary: the ORION-10 and ORION-11 studies look at how well inclisiran works in people with high cholesterol
23rd May 2023 Plain Language Summary: the MAIA study, daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma
23rd May 2023 Plain Language Summary: the results from two phase 3 studies on the efficacy and safety of daridorexant in patients with chronic insomnia disorder:
25th Nov 2022 Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study